Radiofrequency ablation of neuroendocrine liver metastases

Elvin, Anders; Skogseid, Britt; Hellman, Per

doi:10.1007/s00261-004-0257-5

Cited by 44 publications

(44 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The Downs and Black checklist was modified by one of the present authors (H.M.) to allow it to be used to assess study quality for the present series of nonrandomized studies. With this modified score, a maximum score of 14 was possible, with higher scores reflecting higher quality of studies (Table E2 [ 14,15,[29][30][31][32][33][34], available online at www.jvir.org). In view of the low quality of studies in the present review, a meta-analysis was not performed.…”

Section: Quality Assessmentmentioning

confidence: 99%

“…Surgical options include resection or rarely transplantation, but the majority of patients do not have resectable or "transplantable" disease at presentation, and surgery carries a high recurrence rate (13)(14)(15)(16). Somatostatin analogues are the most effective pharmacologic therapy for symptom control, and traditional chemotherapy has limited efficacy (17,18).…”

mentioning

confidence: 99%

See 1 more Smart Citation

Radiofrequency Ablation for Neuroendocrine Liver Metastases: A Systematic Review

Mohan¹,

Nicholson²,

Winter³

et al. 2015

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

Section: Quality Assessmentmentioning

confidence: 99%

mentioning

confidence: 99%

Radiofrequency Ablation for Neuroendocrine Liver Metastases: A Systematic Review

Mohan¹,

Nicholson²,

Winter³

et al. 2015

Journal of Vascular and Interventional Radiology

View full text Add to dashboard Cite

“…Successful use of RF ablation in the treatment of HCC and colorectal metastases led to the utilization of this technique to treat liver metastases from other primaries. Although metastases from any primary, providing their appropriate number, size and location, can be treated with RF ablation, more experience has been accumulated in metastases from breast carcinoma and neuroendocrine malignancies (29,30).…”

Section: Rf Ablation In Liver Tumorsmentioning

confidence: 99%

Radiofrequency ablation: technique and clinical applications

Tatlı

Tapan²,

Morrison³

et al. 2011

Diagn Interv Radiol

View full text Add to dashboard Cite

Radiofrequency ablation is the most commonly used percutaneous ablation technique and well-documented in the literature on focal therapies. It has become the image-guided ablation method of choice because of its efficacy, safety, and ease of use. Radiofrequency ablation has shown promise in treating selected solid tumors, particularly those involving the liver, kidneys, lungs, and the musculoskeletal system. It is a minimally invasive technique often used in inoperable patients with other comorbidities. Radiofrequency ablation requires a minimal hospital stay or can be performed on an outpatient basis. The aim of this article is to review radiofrequency ablation techniques and their clinical applications.

show abstract

“…Metastasen mit maximal 3-5 cm Durchmesser werden intraoperativ (laparoskopisch oder offen chirurgisch) oder perkutan unter Ultraschall-, CT-oder MRT-Kontrolle koaguliert [44,45]. Ähnlich wie bei der TACE sind die Schwere und Häufigkeit auftretender Nebenwirkungen abhängig von der Größe des zu behandelnden Tumorherds und der Erfahrung des Untersuchers [46,47].…”

Section: Radiofrequenzinduzierte Thermoablation (Rfta)unclassified

Nichtoperative Therapiemöglichkeiten gastroenteropankreatischer neuroendokriner Tumoren

Busse¹,

Mössner²,

Stümvoll³

et al. 2007

Visc Med

View full text Add to dashboard Cite

Gastroenteropancreatic neuroendocrine tumors (NET) are an extremely heterogeneous entity with respect to their biological behavior and functionality. Considering the diversity of NET, therapeutic approaches should be chosen carefully. Besides surgical resection or tumor debulking, various palliative options including medical, locally ablative and radiotherapeutical interventions are available. In functionally active tumors biotherapy with either somatostatin analogues or interferon alpha is indicated. The results of chemotherapy are often unsatisfactory, and its use is mostly restricted to pancreatic neuroendocrine carcinomas. Here, streptozotocin and 5-fluorouracil or doxorubicin are considered standard first-line therapy. In slowly progressing disease, however, chemotherapy is not effective. In rapidly growing carcinomas etoposide and cisplatin are mostly applied. In the treatment of hepatic metastases, embolization therapy with or without chemotherapy is frequently used when surgery is not an option. Radiofrequency ablation is another alternative. In tumors with strong somatostatin receptor expression, radionuclide therapy is an approach that enables internal radiation therapy. Bearing in mind actually running active clinical trials, we here present a therapeutic algorithm which we hope will facilitate therapeutical decision making.

show abstract

Radiofrequency ablation of neuroendocrine liver metastases

Cited by 44 publications

References 29 publications

Radiofrequency Ablation for Neuroendocrine Liver Metastases: A Systematic Review

Radiofrequency Ablation for Neuroendocrine Liver Metastases: A Systematic Review

Radiofrequency ablation: technique and clinical applications

Nichtoperative Therapiemöglichkeiten gastroenteropankreatischer neuroendokriner Tumoren

Contact Info

Product

Resources

About